Caricamento...
Handling interoccasion variability in model‐based dose individualization using therapeutic drug monitoring data
AIMS: This study aims to assess approaches to handle interoccasion variability (IOV) in a model‐based therapeutic drug monitoring (TDM) context, using a population pharmacokinetic model of coagulation factor VIII as example. METHODS: We assessed 5 model‐based TDM approaches: empirical Bayes estimate...
Salvato in:
| Pubblicato in: | Br J Clin Pharmacol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533430/ https://ncbi.nlm.nih.gov/pubmed/30767254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13901 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|